United States · Investor

Biospring Partners

Filed with the SEC to raise a fund in Apr 2026, closing $5M. Last cheque observed May 2018.

QuietNew fund $5.0M, Apr 2026Private equity

GrowthPharma ServicesBiomanufacturingClinical Trial Services

Cheques on record
0%of best year0cheques in 12 months, 10 on record
Since the last cheque3106days00hrs00min00sec
Median round$2.0MRounds led0 of 10Exits2 from the portfolioMostly inUnited States, 90%
Pitch Biospring Partners

Biospring Partners highlights

  1. 01

    10 rounds on record

  2. 02

    Mostly Seed and Series A: 90% of its rounds

  3. 03

    2 exits from the portfolio

What they do

We partner with technology-enabled, EBITDA-positive pharma services businesses driving innovation in manufacturing and clinical trial servicesFrom their own website
Type
Private equity
Cheque size
Not stated
Stages
Growth
Sectors
Pharma ServicesBiomanufacturingClinical Trial Services
Based in
New York, United States
Cold pitches
Not accepted

The record

Every round we can evidence, newest first10 appearances

  1. 2018

    1 round

  2. May
    SentenaiSeed · US · FinSMEs$2.0MWith 4 others
  3. 2015

    2 rounds

  4. Apr
    CrayonVenture · US$1.5MWith 11 others
  5. Apr
    Blank LabelSeed · US$1.1MWith 6 others
  6. 2014

    2 rounds

  7. Dec
    Gallop LabsSeed · CA$2.0MWith 4 others
  8. Oct
    Remix MediaSeed · US$2.0MWith 6 others
  9. 2013

    1 round

  10. Mar
    clypdSeries A · US · marketwire.com$3.2MWith 10 others
  11. 2012

    1 round

  12. May
    MyTimeSeries A · US · techcrunch.com$3.0MWith 14 others
  13. 2011

    3 rounds

  14. Oct
    CrashlyticsSeed · US · techcrunch.com$1.0MWith 9 others
  15. Aug
    Habit LabsSeed · US · techcrunch.com$250KWith 5 others
  16. Jan
    OnSwipeSeed · US · blog.onswipe.com$1.0MWith 10 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration4 named

JBJeff BullockCFO/CCOiFiling they signed
JLJennifer LumManager and OfficeriFiling they signed
MAMichelle Alexis DetwilerManager and Officer of Biospring Partners Fund II GP, LLC, the "General Partner"iFiling they signed
MDMichelle DippExecutive OfficeriFiling they signed

We also hold 15 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$345Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
Biospring Management, LLC
SEC number
CRD 321694

Exits from the portfolio

Companies it backed that were later bought or listed2 in all

OnSwipeBought by Beanstock MediaUndisclosedAug 2014
CrashlyticsBought by Twitter$100MJan 2013

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Biospring Partners. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Biospring Partners put money into.

Quick answers about Biospring Partners

What does Biospring Partners invest in?

Biospring Partners invests most often at Seed and Series A (90% of the rounds on record), in sectors such as Pharma Services, Biomanufacturing and Clinical Trial Services.

How active is Biospring Partners?

10 investments on record, 0 of them in the last 12 months. The most recent was in May 2018.

What has Biospring Partners invested in recently?

Its most recent investments on record: Sentenai (Seed, May 2018).

How big are Biospring Partners's cheques?

The median round it joins is $2.0M.

Does Biospring Partners lead rounds?

Rarely, if at all: none of its 10 investments on record names it as the lead.

Where does Biospring Partners invest?

Most of the companies it backs are in the United States (90%) and Canada (10%).

Is Biospring Partners investing now?

No investments in the last 12 months; the latest was in May 2018.

Who does Biospring Partners invest alongside?

Most often Roy Rodenstein (3 rounds together), Apricot Capital (2 rounds together) and David Chang (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it